Horizons in Cancer Research. Volume 87

Hiroto S. Watanabe (Herausgeber)

Buch | Hardcover

254 Seiten

2024
Nova Medicine and Health (Verlag)
979-8-89113-885-8 (ISBN)

Infos

This book analyzes advances in cancer research. Chapter 1 will highlight the main features regarding the most outstanding contributions around stimuli-responsive lipid-based nanovesicles and the recent advances in their biomedical applications in cancer. Chapter 2 will more closely discuss the involvement of the AGR protein family in EMT and cancer, with a special focus on AGR2. Chapter 3 covers liquid biopsies, immunotherapy, liquid biopsies, and combinational therapies. Chapter 4 discusses data that will allow revealing additional mechanisms of tumor growth and will be the basis for improving existing antitumor treatment regimens in patients with triple receptor-negative breast cancer, which is characterized by a high degree of malignancy. Chapter 5 reviews the EMT process of cervical cancer cells. Chapter 6 discusses youth SHS exposure and how it is a major public health issue worldwide. Chapter 7 analyzes a specific study dealing with breast biopsy and mammograms of benign and malignant lesions. Chapter 8 reviews the development of Pharmacogenomics studies. Chapter 9 provides an overview of the principles and applications of statistical risk stratification in surgery, highlighting its significance in optimizing patient care and enhancing surgical outcomes.

Produkt-Details

• Erscheinungsdatum: 21.08.2024
• Reihe/Serie: Horizons in Cancer Research
• Sprache: englisch
• Maße: 152 x 229 mm
• Themenwelt: Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie
• ISBN-13: 979-8-89113-885-8 / 9798891138858
• Zustand: Neuware